Additionally, NLR (HR = 1.51, 95% CI = 1.38-1.65) was also significantly associated with poorer PFS.<h4>Discussion</h4>NLR, NEU, SII and Hb are robust and consistent prognostic predictors for patients with RCC receiving targeted therapy. Here, GSTM1 is linked to renal cell carcinoma.